Average Co-Inventor Count = 3.19
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aurigene Discovery Technologies Limited (12 from 44 patents)
2. Aurigene Oncology Limited (4 from 16 patents)
3. Auirgene Discovery Technologies Limited (1 from 1 patent)
17 patents:
1. 12226402 - Dual inhibitors of TIM-3 and PD-1 pathways
2. 12037321 - 1,2,4-oxadiazole derivatives as immunomodulators
3. 12005045 - Method of modulating TIGIT and PD-1 signalling pathways using 1,2,4-oxadiazole compounds
4. 11560403 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signaling pathways
5. 11512060 - 1,2,4-oxadiazole derivatives as immunomodulators
6. 11465976 - 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
7. 11274123 - 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling
8. 10961205 - 1,2,4-oxadiazole derivatives as immunomodulators
9. 10781189 - 1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators
10. 10590093 - 1,2,4-oxadiazole derivatives as immunomodulators
11. 10173989 - 1,2,4-oxadiazole derivatives as immunomodulators
12. 10160736 - 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
13. 10106581 - Cyclic peptidomimetic compounds as immunomodulators
14. 9776978 - 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
15. 9771338 - 1,2,4-oxadiazole derivatives as immunomodulators